Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
201 studies found for:    calcitonin
Show Display Options
Rank Status Study
1 Completed FGF-23 Suppressibility by Calcitonin
Condition: Hypophosphatemia
Interventions: Drug: Calcitonin;   Drug: Placebo
2 Completed Calcitonin for Treating X-linked Hypophosphatemia
Condition: Hypophosphatemic Rickets, X Linked Dominant
Interventions: Drug: nasal salmon calcitonin;   Drug: Saline Nasal Spray Placebo
3 Withdrawn Calcitonin in the Treatment of Fibromyalgia
Condition: Fibromyalgia
Interventions: Drug: salmon calcitonin;   Drug: intranasal saline solution plus glycerol
4 Completed
Has Results
A Study Comparing Oral Calcitonin to Nasal Spray Calcitonin in Postmenopausal Osteoporotic Women
Condition: Osteoporosis, Postmenopausal
Interventions: Drug: Oral Calcitonin Tablets;   Drug: Intranasal Calcitonin;   Drug: Placebo tablets and placebo intranasal spray
5 Completed
Has Results
A Study of Oral Calcitonin Given at Night to Healthy Postmenopausal Women
Condition: Phase 1 Pharmacodynamic Study
Interventions: Drug: Oral rsCT tablet;   Drug: Oral Placebo Tablet;   Drug: Fortical (rsCT) nasal spray
6 Completed A Study to Assess the Disturbances in Calcitonin Gene in Patients With Gum Disease and Osteoporosis
Conditions: Generalized Chronic Periodontitis;   Osteoporosis
Intervention: Genetic: CTR Gene
7 Completed
Has Results
A Study to Evaluate Oral Salmon Calcitonin in the Treatment of Osteoporosis in Postmenopausal Women Taking Calcium and Vitamin D
Condition: Osteoporosis
Interventions: Drug: SMC021 Oral calcitonin;   Drug: SMC021 Placebo
8 Completed Bone Microstructure in Nasal Salmon Calcitonin Treated Postmenopausal Women
Condition: Postmenopause
Intervention: Drug: Salmon calcitonin
9 Terminated
Has Results
Efficacy and Safety of Oral Salmon Calcitonin in Patients With Knee Osteoarthritis (OA 2 Study)
Condition: Osteoarthritis
Interventions: Drug: Oral Salmon Calcitonin;   Drug: Oral Salmon Calcitonin (Placebo)
10 Completed
Has Results
Efficacy and Safety of Oral Salmon Calcitonin in Patients With Knee Osteoarthritis
Condition: Osteoarthritis
Interventions: Drug: SMC021 Oral Calcitonin;   Drug: SMC021 Placebo
11 Completed Epidural Calcitonin in Lower Limb Amputation
Condition: Amputation Stumps
Interventions: Drug: Calcitonin;   Drug: Fentanyl
12 Completed
Has Results
A Study of Oral Recombinant Salmon Calcitonin (rsCT) to Prevent Postmenopausal Osteoporosis
Condition: Osteopenia
Interventions: Drug: Oral calcitonin at dinnertime;   Drug: Oral placebo at dinnertime;   Drug: Oral calcitonin at bedtime;   Drug: Oral placebo at bedtime
13 Completed Nasal Calcitonin in the Treatment of Bone Mineral Loss in Children and Adolescents With Inflammatory Bowel Disease
Conditions: Ulcerative Colitis;   Crohn's Disease
Intervention: Drug: Calcitonin nasal spray (salmon)
14 Terminated Analgesic Effect of Intranasal Calcitonin on Patients With Fractured Ribs
Conditions: Rib Fractures;   Pain
Intervention: Drug: Intranasal calcitonin
15 Completed Efficacy and Safety of Salmon Calcitonin Nasal Spray in Improving Muscle Strength and Reducing Pain After Forearm Fracture in Postmenopausal Women
Condition: Forearm Fracture
Intervention: Drug: Salmon calcitonin
16 Completed Effects of Water and Food Intake on the Pharmacokinetics and Pharmacodynamics of Oral Salmon Calcitonin in Healthy Postmenopausal Women
Condition: Postmenopausal Osteoporosis
Intervention: Drug: Oral salmon calcitonin, salmon calcitonin nasal spray
17 Unknown  Pro-calcitonin Marker as Indicator of Ischemia in Patients With Complicated Coronary Intervention.
Condition: Coronary Disease
Intervention:
18 Terminated Effects of Oral Salmon Calcitonin in Human Osteoarthritis
Condition: Osteoarthritis
Intervention: Drug: oral salmon calcitonin
19 Completed A Study of the Treatment of Postmenopausal Women With Osteoporosis
Condition: Osteoporosis, Post-Menopausal
Interventions: Drug: teriparatide 20 micrograms/day subcutaneous;   Drug: salmon calcitonin 100 IU/day subcutaneous
20 Completed Comparison Medications in the Treatment of Postmenopausal Women With Osteoporosis
Condition: Osteoporosis, Postmenopausal
Interventions: Drug: teriparatide 20 micrograms/day subcutaneous;   Drug: salmon calcitonin 100 IU/day subcutaneous

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.